Rapid administration of methoxyflurane versus standard care for pain management in the ED
According to findings of the controlled randomized trial, secondary outcomes included the pain score at multiple time points and the difference in the proportion of patients achieving a >2 point reduction on the pain numerical rating scale. Additionally, methoxyflurane use was not associated with any serious adverse events and was not associated with a significant change in opioid use among emergency department patients.
The lead author of the study is Lisa Brichko, MBBS (Hons), DCH, MHM, of the Emergency and Trauma Centre at Alfred Health in Melbourne, Australia. The findings of the study are discussed with the author in a recent AEM podcast titled The RAMPED Trial - It's a Gas, Gas, Gas.
INFORMATION:
ABOUT ACADEMIC EMERGENCY MEDICINE
Academic Emergency Medicine, the monthly journal of Society for Academic Emergency Medicine, features the best in peer-reviewed, cutting-edge original research relevant to the practice and investigation of emergency care. The above study is published open access and can be downloaded by following the DOI link: 10.1111/acem.14144. Journalists wishing to interview the authors may contact Tami Craig at tcraig@saem.org.
ABOUT THE SOCIETY FOR ACADEMIC EMERGENCY MEDICINE
SAEM is a 501(c)(3) not-for-profit organization dedicated to the improvement of care of the acutely ill and injured patient by leading the advancement of academic emergency medicine through education and research, advocacy, and professional development. To learn more, visit saem.org.
